Weight fluctuations and psychotropic drugs: Neuroleptics;Fluctuations pondérales et traitements psychotropes: Les neuroleptiques

Encephale

Volumn 27, Issue 3, 2001, Pages 269-276

  Recasens, C ^a  

^a Hopital Albert Chenevier   (France)

Author keywords

Eating behavior; Energetic balance; Neuroleptic; Pathophysiological; Side effect; Tolerance; Weight gain

Indexed keywords

ACETYLCHOLINE; CLOZAPINE; DOPAMINE; HISTAMINE; LOXAPINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN;

ARTICLE; ENERGY BALANCE; FEEDING BEHAVIOR; OBESITY; PATHOPHYSIOLOGY; PATIENT CARE; RELAPSE; SELF CONCEPT; SELF ESTEEM; SOMATIZATION; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BRAIN; FEMALE; HUMANS; MALE; OBESITY; PSYCHOTIC DISORDERS; RECEPTORS, NEUROTRANSMITTER; RISK FACTORS; WEIGHT GAIN;

EID: 0034921260     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Antipsychotic-induced weight gain: A comprehensive research synthesis
2. Drug-produced obesity: Experiences with chlorpromazine, perphenazine and clopenthixol
3. Body weight gain induced by antipsychotic drugs: Mechanisms and management
4. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: Relationship with body weight regulation
5. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy premenopausal women: Relationship with body weight regulation
6. Mechanism of the neuroleptic-induced obesity in female rats
7. Possible clozapine exacerbation of bulimia nervosa
8. Serum leptin levels increase rapidly after initiation of clozapine therapy
9. Differential effects of clozapine on weight: A controlled study
10. The relationship of pharmacology to side effects
11. Side effects during long term treatment with depot antipsychotic medication
12. Risperidone, weight gain and bulimia nervosa
13. The effects of antipsychotic drugs on body weight: A retrospective review
14. Weight gain associated with use of psychotropic medications
15. Weight reduction in schizophrenics by molindone
16. Clozapine-associated elevation in serum triglycerides
17. Weight gain induced by clozapine
18. Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats
19. Body weight and leptin plasma levels during treatment with antipsychotic drugs
20. Antipsychotic drug-induced obesity in rats: Correlation between leptin, insulin and body weight during sulpiride treatment
21. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: A 12 year follow-up of participants in the population study of women in Gothenburg, Sweden
22. Clozapine-induced weight gain: Prevalence and clinical relevance
23. Brain catecholaminergic mechanisms for control of hunger
24. Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients
25. Adjunctive loxapine in a clozapine resistant cohort of schizophrenic patients
26. Olanzapine increases weight and serum triglyceride levels
27. Weight gain associated with risperidone
28. Reduced rate of energy expenditure as a risk factor for body-weight gain
29. Weight gain associated with use of psychotropic medications
30. Prevalence of obesity in patients receiving depot antipsychotics
31. The distribution of adipose tissue in female patients receiving psychotropic drugs
32. Novel antipsychotics: Comparison of weight gain liabilities
33. Novel antipsychotics and new onset diabetes